Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: Study of the Immune Response to Hepatitis C Virus
This entry reports the completion of a clinical trial examining the immune response to hepatitis C virus.
-
CLINICAL_TRIALS trial_result · 2010-11-17Clinical Trial Update: Trial of Pegasys® in Patients With Chronic Hepatitis C [Phase 4]
This document reports the completion of a Phase 4 clinical trial evaluating Pegasys in patients with chronic hepatitis C.
-
CLINICAL_TRIALS research · 2010-11-05Clinical Trial Update: The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy [Phase 2]
An update on a Phase 2 clinical trial investigating whether bacterial overgrowth and delayed intestinal transit contribute to hepatic enceph…
-
CLINICAL_TRIALS trial_result · 2010-11-04Clinical Trial Update: Double-Blind, Dose-Escalation Study of IDX184 in Chronic Hepatitis C Treatment-Naïve Subjects [Phase 1, Phase 2]
ClinicalTrials.gov entry reports the results of a double-blind, dose-escalation study of IDX184 in treatment-naïve chronic hepatitis C patie…
-
CLINICAL_TRIALS trial_result · 2010-10-28Clinical Trial Update: Chronic Hepatitis C Non-Responder Study With AdoMet and Betaine [Phase 2, Phase 3]
Clinical trial update reporting the completed Phase 2/3 study of AdoMet (S-adenosyl-L-methionine) and Betaine for chronic hepatitis C patien…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-10-27Clinical Trial Update: Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-responders [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluated adding interferon-gamma to interferon-alpha and ribavirin for hepatitis C in patients who did…
-
CLINICAL_TRIALS trial_result · 2010-10-25Clinical Trial Update: A Study of Single Doses of ABT-072 in Japanese Healthy Male Adults [Phase 1]
A Phase 1 study evaluating single doses of ABT-072 in healthy Japanese male adults, with Hepatitis C listed as the condition; the trial stat…
-
CLINICAL_TRIALS trial_result · 2010-10-25Clinical Trial Update: A Study of Single Dose of ABT-333 in Healthy Male Adults [Phase 1]
Phase 1 single-dose study of ABT-333 in healthy male adults completed; assesses safety and pharmacokinetics in the context of hepatitis C in…
-
CLINICAL_TRIALS trial_result · 2010-10-21Clinical Trial Update: Evaluation of the Bioavailability of Two ABT-072 Tablet Formulations as Compared to ABT-072 Capsule Formulation [Phase 1]
This Phase 1 study evaluated the relative bioavailability of two ABT-072 tablet formulations compared with the ABT-072 capsule formulation i…
-
CLINICAL_TRIALS trial_result · 2010-10-21Clinical Trial Update: A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults [Phase 1]
Abbott conducted a Phase 1 study of ABT-072 in healthy adults and patients with hepatitis C virus genotype 1; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2010-10-21Clinical Trial Update: A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat Hepatitis C [Phase 1]
This Phase 1 study in healthy adults evaluated the safety, tolerability, and pharmacokinetics of multiple doses of ABT-072 for hepatitis C, …
-
CLINICAL_TRIALS trial_result · 2010-10-21Clinical Trial Update: Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected Patients [Phase 4]
This record summarizes the completion of a Phase 4 clinical trial evaluating pegylated interferon therapy for acute hepatitis C infection in…
-
CLINICAL_TRIALS research · 2010-10-21Clinical Trial Update: Single and Multiple Dose Evaluation of ABT-072 and to Evaluate the Effect of Food on the Pharmacokinetics of ABT-072 [Phase 1]
Phase 1 clinical trial update evaluating single and multiple doses of ABT-072 and the effect of food on its pharmacokinetics in Hepatitis C,…
-
CLINICAL_TRIALS trial_result · 2010-10-13Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of the ABT-333 Tablet [Phase 1]
A Phase 1 study assessing safety, tolerability, and pharmacokinetics of multiple ascending doses of the ABT-333 tablet in Hepatitis C patien…
-
CLINICAL_TRIALS trial_result · 2010-10-13Clinical Trial Update: Bioavailability of ABT-333 Tablet Versus First in Human (FIH) Capsule Formulation and Safety, Tolerability and PK Study of Single Doses of ABT-333 in Healthy Volunteers [Phase 1]
Phase 1 study comparing ABT-333 tablet to the first-in-human capsule, examining bioavailability and assessing safety, tolerability, and sing…
-
CLINICAL_TRIALS trial_result · 2010-10-13Clinical Trial Update: Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir [Phase 1]
Phase 1 study in healthy adults evaluating the pharmacokinetics, safety, and tolerability of ABT-450 boosted with ritonavir for potential he…
-
CLINICAL_TRIALS trial_result · 2010-10-13Clinical Trial Update: A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ABT-333 [Phase 1]
Phase 1 study in healthy adults to evaluate safety, tolerability, and pharmacokinetics of multiple doses of ABT-333 for hepatitis C infectio…
-
CLINICAL_TRIALS trial_result · 2010-09-20Clinical Trial Update: Adherence in Patients Receiving PegIntron/Rebetol for Hepatitis C in Conjunction With a Psychotherapy Support Program (Study P04252)
A completed clinical trial evaluated adherence to PegIntron (pegylated interferon alfa-2b) and Rebetol (ribavirin) in Hepatitis C patients w…
-
CLINICAL_TRIALS trial_result · 2010-09-16Clinical Trial Update: Study of CTS-1027 in Hepatitis C Patients [Phase 2]
Conatus Pharmaceuticals' Phase 2 trial of CTS-1027 in patients with chronic hepatitis C infection has completed.
-
CLINICAL_TRIALS trial_result · 2010-09-13Clinical Trial Update: A Single Ascending Dose Study of BMS-650032 in HCV Infected Subjects [Phase 1, Phase 2]
This clinical trial update summarizes a single ascending dose study of BMS-650032 in adults with hepatitis C, covering Phase 1/2, whose stat…
-
CLINICAL_TRIALS trial_result · 2010-09-08Clinical Trial Update: Pegylated Interferon Plus Ribavirin in Treating Older Patients With Chronic Hepatitis C [Phase 4]
Phase 4 clinical trial update evaluating pegylated interferon plus ribavirin in older adults with chronic hepatitis C. The study assesses sa…
-
CLINICAL_TRIALS research · 2010-09-08Clinical Trial Update: Immune Dysregulation in Hepatitis C Patients With or Without Arthritis
This clinical trial update examines immune dysregulation in hepatitis C patients, comparing those with and without arthritis.
-
CLINICAL_TRIALS trial_result · 2010-09-06Clinical Trial Update: Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice. [Phase 4]
Phase 4 clinical trial evaluating different schedules of pegylated interferon and ribavirin for chronic hepatitis C in real-world practice. …
-
CLINICAL_TRIALS trial_result · 2010-09-03Clinical Trial Update: Immunotherapy With TG4040 in Treatment-naïve Patients Chronically Infected With Hepatitis C Virus [Phase 1]
This document reports the completion of a Phase 1 trial of TG4040 immunotherapy in treatment-naïve patients chronically infected with hepati…
-
CLINICAL_TRIALS trial_result · 2010-09-01Clinical Trial Update: Efficacy and Safety of Basiliximab in Hepatitis C Virus Positive Patients Undergoing Liver Transplantation [Phase 3]
Phase 3 trial evaluating the efficacy and safety of basiliximab in hepatitis C virus–positive patients undergoing liver transplantation has …